<VariationArchive VariationID="1453222" VariationName="NM_001367721.1(CASK):c.1652_1655dup (p.Gln553fs)" VariationType="Duplication" Accession="VCV001453222" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1428508" VariationID="1453222">
      <GeneList>
        <Gene Symbol="CASK" FullName="calcium/calmodulin dependent serine protein kinase" GeneID="8573" HGNC_ID="HGNC:1497" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="41514934" stop="41923554" display_start="41514934" display_stop="41923554" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="41374186" stop="41782286" display_start="41374186" display_stop="41782286" Strand="-" />
          </Location>
          <OMIM>300172</OMIM>
          <Haploinsufficiency last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CASK">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CASK">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001367721.1(CASK):c.1652_1655dup (p.Gln553fs)</Name>
      <CanonicalSPDI>NC_000023.11:41561571:AGTT:AGTTAGTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="41561571" stop="41561572" display_start="41561571" display_stop="41561572" variantLength="4" positionVCF="41561571" referenceAlleleVCF="C" alternateAlleleVCF="CAGTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="41420824" stop="41420825" display_start="41420824" display_stop="41420825" variantLength="4" positionVCF="41420824" referenceAlleleVCF="C" alternateAlleleVCF="CAGTT" />
      </Location>
      <ProteinChange>Q553fs</ProteinChange>
      <ProteinChange>Q547fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.41420825_41420828dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.41420825_41420828dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.41561572_41561575dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.41561572_41561575dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016754.2" sequenceAccession="NG_016754" sequenceVersion="2" change="g.366460_366463dup">
            <Expression>NG_016754.2:g.366460_366463dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126054.3" sequenceAccession="NM_001126054" sequenceVersion="3" change="c.1652_1655dup">
            <Expression>NM_001126054.3:c.1652_1655dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119526.1" sequenceAccession="NP_001119526" sequenceVersion="1" change="p.Gln553Thrfs">
            <Expression>NP_001119526.1:p.Gln553Thrfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001126055.3" sequenceAccession="NM_001126055" sequenceVersion="3" change="c.1634_1637dup">
            <Expression>NM_001126055.3:c.1634_1637dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001119527.1" sequenceAccession="NP_001119527" sequenceVersion="1" change="p.Gln547Thrfs">
            <Expression>NP_001119527.1:p.Gln547Thrfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001367721.1" sequenceAccession="NM_001367721" sequenceVersion="1" change="c.1652_1655dup" MANESelect="true">
            <Expression>NM_001367721.1:c.1652_1655dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001354650.1" sequenceAccession="NP_001354650" sequenceVersion="1" change="p.Gln553fs">
            <Expression>NP_001354650.1:p.Gln553fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410745.1" sequenceAccession="NM_001410745" sequenceVersion="1" change="c.1634_1637dup">
            <Expression>NM_001410745.1:c.1634_1637dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397674.1" sequenceAccession="NP_001397674" sequenceVersion="1" change="p.Gln547Thrfs">
            <Expression>NP_001397674.1:p.Gln547Thrfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003688.4" sequenceAccession="NM_003688" sequenceVersion="4" change="c.1652_1655dup">
            <Expression>NM_003688.4:c.1652_1655dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003679.2" sequenceAccession="NP_003679" sequenceVersion="2" change="p.Gln553Thrfs">
            <Expression>NP_003679.2:p.Gln553Thrfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2147155759" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001367721.1(CASK):c.1652_1655dup (p.Gln553fs) AND Intellectual disability, CASK-related, X-linked" Accession="RCV001994755" Version="3">
        <ClassifiedConditionList TraitSetID="3147">
          <ClassifiedCondition DB="MedGen" ID="CN043158">Intellectual disability, CASK-related, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19165920</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20029458</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21954287</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22452838</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22709267</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3147" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9049" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, CASK-related, X-linked</ElementValue>
                <XRef ID="X-linked+mental+retardation%2C+CASK-related/9513" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">CASK disorders include a spectrum of phenotypes in both females and males. Two main types of clinical presentation are seen: Microcephaly with pontine and cerebellar hypoplasia (MICPCH), generally associated with pathogenic loss-of-function variants in CASK. X-linked intellectual disability (XLID) with or without nystagmus, generally associated with hypomorphic CASK pathogenic variants. MICPCH is typically seen in females with moderate-to-severe intellectual disability, progressive microcephaly with or without ophthalmologic anomalies, and sensorineural hearing loss. Most are able to sit independently; 20%-25% attain the ability to walk; language is nearly absent in most. Neurologic features may include axial hypotonia, hypertonia/spasticity of the extremities, and dystonia or other movement disorders. Nearly 40% have seizures by age ten years. Behaviors may include sleep disturbances, hand stereotypies, and self biting. MICPCH in males may occur with or without severe epileptic encephalopathy in addition to severe-to-profound developmental delay. When seizures are present they occur early and may be intractable. In individuals and families with milder (i.e., hypomorphic) pathogenic variants, the clinical phenotype is usually that of XLID with or without nystagmus and additional clinical features. Males have mild-to-severe intellectual disability, with or without nystagmus and other ocular features. Females typically have normal intelligence with some displaying mild-to-severe intellectual disability with or without ocular features.</Attribute>
                <XRef ID="NBK169825" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24278995</ID>
                <ID Source="BookShelf">NBK169825</ID>
              </Citation>
              <XRef ID="CN043158" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4251977" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="12118273|MedGen:C2749054" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002235691" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19165920</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20029458</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21954287</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22452838</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22709267</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1453222). This variant has not been reported in the literature in individuals affected with CASK-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln553Thrfs*6) in the CASK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CASK are known to be pathogenic (PMID: 19165920, 20029458, 21954287, 22452838, 22709267).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CASK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.41420824_41420825insAGTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2749054" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4251977" TraitType="Disease" MappingType="XRef" MappingValue="C2749054" MappingRef="MedGen">
        <MedGen CUI="CN043158" Name="Intellectual disability, CASK-related, X-linked" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

